期刊文献+

结核分枝杆菌rv3873基因原核表达载体的构建、表达和纯化 被引量:1

Construction and expression of prokaryotic expression vector of mycobacterium tuberculosis rv3873 gene and its purification
原文传递
导出
摘要 目的构建结核分枝杆菌(M.tb)rv3873基因原核表达载体并进行表达。方法用聚合酶链反应(PCR)扩增MTBrv3873基因,并克隆入pGEM~TEasy质粒。测序正确后,再亚克隆入pET30a(+)质粒,构建pET30a(+):rv3873重组体。结果以重组体分别转化DH5a和BL21(DE3)菌后,经0.4mmol/L异丙基硫代-β-D-半乳糖苷(IPTG)诱导,pET30a(+):rv3873表达出相对分子质量为47000左右的重组蛋白。SDS-PAGE分析显示,IPTG诱导4h重组蛋白的表达量最高。表达蛋白以包涵体形式存在于胞质中,表达量占全菌蛋白质的50%,Westernblot证实其具有良好的抗原性。经Ni-NTA柱纯化,获得纯度为90%的重组蛋白。结论成功地构建原核表达载体pET30a(+):rv3873,并获得重组Rv3873蛋白,为辅助诊断结核菌的感染奠定了基础。 Objective To construct prokaryotic expression vector carrying rv3873 gene and express it in Escheridia coli(E, coli). Methods The mycobacterium tuberculosis(M, tb) rv3873 gene was amplified by polymerase chain reaction(PCR) and then cloned into plasmid pGEM-T Easy. After sequencing, the gene was cloned into plasmid pET30a(+ ) to construct recombinant prokaryotic expression vector pET30a( + ): rv3873. Results After transformation of the E. coli and induction with 0.4 mmol/L of IPTG, recombinant target protein Rv3873 with Mr 47 000 was expressed in pET30a (+): rv3873 system, and the expressed protein was the maximum when induced with IPTG for 4 h; The expressed protein existed in cytoplasm in unsoluble form and amounted to 50% of total protein of E. coll. Western blot analysis showed that the protein had good antigenicity. The purity of the protein purified through the Ni-NTA resin reached 90%. Conclusions The prokaryotic expression vector pET30a (+): rv3873 was constructed successfully and the recombinant protein Rv3873 was obtained,which laid the foundation for application in the diagnosis of tuberculosis.
出处 《国际呼吸杂志》 2007年第17期1292-1295,共4页 International Journal of Respiration
基金 北京市优秀人才培养资助基金资助(编号:2005)
关键词 结核分枝杆菌 rv3873基因 Rv3873重组蛋白 Mycobacterium tuberculosis rv3873 gene Recombinant Rv3873
  • 相关文献

参考文献6

  • 1Limei MO,Inger B, Frank F, et al. PPE protein (Rv3873) from DNA segment RD/ of mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family. Infect Immun,2003,71 :6116-6123.
  • 2Maheiras GG, Sabo PJ, Hickey MJ, et al. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol, 1996,178: 1274-1282.
  • 3Behr MA, Wilson MA, Gill WP, et al. Comparative genomics of BCG vavvines by whole genome DNA microarray. Science, 1999, 284 : 1520-1523.
  • 4Cockle PJ, Gordon SV, Lalvant A, et al. Identification of novel Myeobaeterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics. Infect Immun, 2002,70 : 6996-7003.
  • 5Hewinson RG, Vordermeier HM,Buddle BM. Use of the bovine modle of tuberculosis for the development of improved vaccines and diagnostics. Tuberculosis, 2003,83: 119-130.
  • 6Liu XQ, Davinder D, Hansa V, et al. Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection. Infect Immun, 2004,72: 2574-2581.

同被引文献7

  • 1蒋天舒,娄加陶,周晔,陈燕,陈波,谷明莉,仲人前,邓安梅.结核分枝杆菌抗原Rv0173的克隆、表达与纯化[J].中国实验诊断学,2007,11(7):914-916. 被引量:1
  • 2Ginsberg AM, Spigelman M. Challenges in tuberculosis drug research and development. Nature, 2007, 13: 290-294.
  • 3Chaisson SE. From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis. Nature Medicine, 2007, 13(3): 295-298.
  • 4Cegielshi JP, Chin DP, Espinal MA, et al. The global tuberculosis situation: Progress and broblems in the 20th century, prospects for the 21st century. Infect Dis Clin North Am, 2002, 16: 1-58.
  • 5J萨姆布鲁克,弗里奇,曼尼阿蒂斯T著.分子克隆实验指南.第二版.金冬雁,黎孟枫等译.北京:科学出版社,1995,pp.891-897.
  • 6Kwasi G.Mawuenyega, Christian VF, et al. Mycobacterium tuberculosis functional network analysis by global subcellular protein profiling. Molecular Biology of the cell, 2005, 16: 396-404.
  • 7Abebe F, Holm-Hansen C, Wiker HG, et al. Progress in serodiagnosis of Mycobacterium tuberculosis infection. Journal of Immunology, 2007, 66: 176-191.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部